tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
United Therapeutics price target raised to $447 from $435 at Morgan Stanley
PremiumThe FlyUnited Therapeutics price target raised to $447 from $435 at Morgan Stanley
2M ago
United Therapeutics: Hold Rating Amid Optimistic Partnership Prospects and Adjusted Revenue Goals
Premium
Ratings
United Therapeutics: Hold Rating Amid Optimistic Partnership Prospects and Adjusted Revenue Goals
2M ago
United Therapeutics Reports Record Q3 2025 Results
Premium
Company Announcements
United Therapeutics Reports Record Q3 2025 Results
2M ago
United Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients
PremiumCompany AnnouncementsUnited Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients
2M ago
United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension
Premium
Company Announcements
United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension
2M ago
United Therapeutics Advances Ralinepag Study for PAH Treatment
Premium
Company Announcements
United Therapeutics Advances Ralinepag Study for PAH Treatment
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100